Latest Insider Transactions at Yumanity Therapeutics, Inc. (YMTX)
This section provides a real-time view of insider transactions for Yumanity Therapeutics, Inc. (YMTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of YUMANITY THERAPEUTICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of YUMANITY THERAPEUTICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 03
2022
|
Devin Whittemore Smith SVP and General Counsel |
SELL
Open market or private sale
|
Direct |
2,923
-14.62%
|
$2,923
$1.19 P/Share
|
|
Jun 03
2022
|
Marie Epstein Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,806
-14.26%
|
$1,806
$1.19 P/Share
|
|
Mar 28
2022
|
Richard Peters |
SELL
Open market or private sale
|
Direct |
10,715
-8.48%
|
$10,715
$1.85 P/Share
|
|
Feb 03
2022
|
Paulash Mohsen Chief Business Officer |
SELL
Open market or private sale
|
Direct |
1,958
-3.2%
|
$1,958
$1.83 P/Share
|
|
Dec 01
2021
|
Devin Whittemore Smith SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Dec 01
2021
|
Richard Peters |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+35.64%
|
-
|
|
Dec 01
2021
|
Paulash Mohsen Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+24.66%
|
-
|
|
Dec 01
2021
|
Michael D Wyzga Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Dec 01
2021
|
Marie Epstein Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,665
+50.0%
|
-
|
|
Dec 01
2021
|
Ajay Verma EVP, Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+50.0%
|
-
|
|
Jul 06
2021
|
Richard Peters |
SELL
Payment of exercise price or tax liability
|
Direct |
79
-0.14%
|
$790
$10.79 P/Share
|
|
Jul 02
2021
|
Richard Peters |
SELL
Payment of exercise price or tax liability
|
Direct |
4,441
-7.29%
|
$48,851
$11.11 P/Share
|
|
Feb 01
2021
|
N Anthony Coles Executive Chair |
BUY
Grant, award, or other acquisition
|
Direct |
1,118
+0.16%
|
-
|
|
Feb 01
2021
|
Cecil B Pickett Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,959
+19.44%
|
-
|
|
Feb 01
2021
|
Richard A. Heyman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,959
+19.44%
|
-
|
|
Feb 01
2021
|
Jeffery W. Kelly Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,959
+12.89%
|
-
|
|
Feb 01
2021
|
Richard Peters |
BUY
Grant, award, or other acquisition
|
Direct |
60,943
+50.0%
|
-
|
|
Feb 01
2021
|
Paulash Mohsen Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,665
+10.19%
|
-
|
|
Dec 22
2020
|
N Anthony Coles Executive Chair |
BUY
Grant, award, or other acquisition
|
Indirect |
52,669
+50.0%
|
-
|
|
Dec 22
2020
|
N Anthony Coles Executive Chair |
BUY
Grant, award, or other acquisition
|
Direct |
689,890
+50.0%
|
-
|
|
Dec 22
2020
|
David Arkowitz |
BUY
Grant, award, or other acquisition
|
Direct |
4,347
+50.0%
|
$99,981
$23.0 P/Share
|
|
Dec 22
2020
|
Richard A. Heyman Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,158
+50.0%
|
-
|
|
Dec 22
2020
|
Jeffery W. Kelly Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,158
+35.32%
|
-
|
|
Dec 22
2020
|
Paulash Mohsen Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,428
+50.0%
|
-
|
|
Dec 22
2020
|
Cecil B Pickett Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,158
+50.0%
|
-
|
|
Dec 14
2017
|
Cormorant Asset Management, LP > 10% Shareholder |
BUY
Open market or private sale
|
Indirect |
504,027
+13.25%
|
$2,016,108
$4.88 P/Share
|
|
Feb 17
2016
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
375,000
+16.68%
|
$3,000,000
$8.0 P/Share
|
|
Feb 17
2016
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,498,791
+50.0%
|
-
|